down arrow

Cronos Group, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA22717L1013
CAD
3.49
0.06 (1.75%)

Dec 04

TSE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

3.473.54

52 Week

2.274.40
Valuation
Technical
Day's Volume

CASH

97.76 k

Shareholding (Mar 2025)

FII

13.92%

Held by 321 FIIs

DII

85.59%

Held by 7 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

The company has declared Positive results for the last 7 consecutive quarters

  • OPERATING CASH FLOW(Y) Highest at CAD 27.45 MM
  • OPERATING PROFIT MARGIN(Q) Highest at -1.06 %
  • RAW MATERIAL COST(Y) Fallen by -120.64% (YoY)
2

With ROE of 1.42%, it has a attractive valuation with a 0.92 Price to Book Value

3

Increasing Participation by Institutional Investors

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 1,353 Million (Small Cap)

stock-summary
P/E

66.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.77

stock-summary
Return on Equity

1.42%

stock-summary
Price to Book

0.92

Revenue and Profits:
Net Sales:
46 Million
(Quarterly Results - Jun 2025)
Net Profit:
-53 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0.29%
0%
0.29%
6 Months
31.2%
0%
31.2%
1 Year
22.03%
0%
22.03%
2 Years
23.32%
0%
23.32%
3 Years
-25.27%
0%
-25.27%
4 Years
-34.64%
0%
-34.64%
5 Years
-69.12%
0%
-69.12%

Cronos Group, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
30.84%
EBIT Growth (5y)
12.06%
EBIT to Interest (avg)
-152.00
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.78
Sales to Capital Employed (avg)
0.09
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
17.06%
ROCE (avg)
0
ROE (avg)
1.03%
Valuation key factors
Factor
Value
P/E Ratio
66
Industry P/E
Price to Book Value
0.94
EV to EBIT
-4.67
EV to EBITDA
-7.10
EV to Capital Employed
0.74
EV to Sales
1.38
PEG Ratio
0.06
Dividend Yield
NA
ROCE (Latest)
-15.78%
ROE (Latest)
1.42%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 7 Schemes (0.5%)

Foreign Institutions

Held by 321 Foreign Institutions (13.92%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 0.00% vs 9.20% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -580.18% vs -81.92% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "46.30",
          "val2": "46.30",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.50",
          "val2": "-1.00",
          "chgp": "50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.90",
          "val2": "-0.70",
          "chgp": "-171.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-53.30",
          "val2": "11.10",
          "chgp": "-580.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-136.20%",
          "val2": "-109.00%",
          "chgp": "-2.72%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 36.87% vs 4.25% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 157.62% vs 52.92% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "161.10",
          "val2": "117.70",
          "chgp": "36.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-67.40",
          "val2": "-97.20",
          "chgp": "30.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-7.70",
          "val2": "-54.50",
          "chgp": "85.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "54.80",
          "val2": "-95.10",
          "chgp": "157.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-497.50%",
          "val2": "-916.00%",
          "chgp": "41.85%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
46.30
46.30
Operating Profit (PBDIT) excl Other Income
-0.50
-1.00
50.00%
Interest
0.00
0.00
Exceptional Items
-1.90
-0.70
-171.43%
Consolidate Net Profit
-53.30
11.10
-580.18%
Operating Profit Margin (Excl OI)
-136.20%
-109.00%
-2.72%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 0.00% vs 9.20% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -580.18% vs -81.92% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
161.10
117.70
36.87%
Operating Profit (PBDIT) excl Other Income
-67.40
-97.20
30.66%
Interest
0.00
0.00
Exceptional Items
-7.70
-54.50
85.87%
Consolidate Net Profit
54.80
-95.10
157.62%
Operating Profit Margin (Excl OI)
-497.50%
-916.00%
41.85%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 36.87% vs 4.25% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 157.62% vs 52.92% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Cronos Group, Inc. stock-summary
stock-summary
Cronos Group, Inc.
Pharmaceuticals & Biotechnology
Cronos Group Inc is a cannabinoid company. The Company is focused on cannabis research, technology and product development. The Company’s portfolio includes PEACE NATURALS, COVE, Spinach, Lord Jones and PEACE+. PEACE NATURALS a global wellness platform. The COVE and Spinach are adult-use brands. The Lord Jones and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Company’s segments include United States and Rest of World. The United States segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s subsidiaries include Cronos Israel G.S. Cultivations Ltd, Cronos Israel G.S. Manufacturing Ltd, Cronos Israel G.S. Store Ltd and Cronos Israel G.S. Pharmacies Ltd.
Company Coordinates stock-summary
Company Details
Suite 300, 111 Peter Street , TORONTO ON : M5V 2G9
stock-summary
Tel: 1 416 5040004
stock-summary
https://thecronosgroup.com/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."